| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,750 |
8,359 |
$444K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,402 |
9,893 |
$351K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,894 |
3,838 |
$341K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,310 |
3,254 |
$271K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,143 |
3,082 |
$263K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,753 |
1,717 |
$145K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,214 |
2,896 |
$61K |
| 92551 |
|
4,804 |
4,704 |
$41K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,321 |
2,159 |
$23K |
| 99173 |
|
4,104 |
4,025 |
$23K |
| 90686 |
|
2,959 |
2,844 |
$11K |
| 90670 |
|
1,848 |
1,787 |
$11K |
| 87428 |
|
280 |
265 |
$8K |
| 90723 |
|
1,390 |
1,351 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
913 |
896 |
$4K |
| 90651 |
|
664 |
636 |
$4K |
| 92552 |
|
944 |
917 |
$3K |
| 90647 |
|
498 |
454 |
$3K |
| 90716 |
|
852 |
823 |
$3K |
| 90681 |
|
795 |
767 |
$3K |
| 96156 |
|
55 |
55 |
$3K |
| 90461 |
|
677 |
631 |
$3K |
| 90707 |
|
844 |
814 |
$2K |
| 90734 |
|
655 |
632 |
$2K |
| 90677 |
|
273 |
273 |
$2K |
| 90648 |
|
1,468 |
1,467 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
253 |
250 |
$2K |
| 90633 |
|
877 |
845 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
525 |
508 |
$1K |
| 90656 |
|
260 |
259 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
42 |
40 |
$543.30 |
| 96127 |
|
86 |
86 |
$473.20 |
| 99499 |
|
13 |
13 |
$421.00 |
| 85018 |
|
215 |
212 |
$304.78 |
| 90696 |
|
283 |
283 |
$273.00 |
| 90700 |
|
213 |
203 |
$259.05 |
| 90715 |
|
262 |
262 |
$252.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$205.40 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
13 |
$197.08 |
| 90620 |
|
250 |
250 |
$91.00 |
| G9920 |
Screening performed and negative |
1,004 |
990 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
89 |
87 |
$0.00 |
| 99442 |
|
13 |
13 |
$0.00 |
| 0071A |
|
174 |
149 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
135 |
129 |
$0.00 |
| 0004A |
|
14 |
13 |
$0.00 |
| 91307 |
|
27 |
27 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
73 |
70 |
$0.00 |
| 0072A |
|
213 |
172 |
$0.00 |
| 0001A |
|
13 |
12 |
$0.00 |